Abivax S.A.
AAVXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $391,687 | $449,623 | $888,213 | $561,657 |
| - Cash | $60,946 | $144,221 | $222,317 | $251,942 |
| + Debt | $98,708 | $97,361 | $113,362 | $55,464 |
| Enterprise Value | $429,449 | $402,763 | $779,258 | $365,179 |
| Revenue | $2,017 | $4,006 | $6,786 | $2,245 |
| % Growth | -49.7% | -41% | 202.3% | – |
| Gross Profit | $2,017 | $4,006 | $6,786 | $1,867 |
| % Margin | 100% | 100% | 100% | 83.2% |
| EBITDA | -$93,594 | -$92,058 | -$79,825 | -$90,047 |
| % Margin | -4,640.3% | -2,298% | -1,176.3% | -4,011% |
| Net Income | -$100,784 | -$94,604 | -$81,638 | -$95,787 |
| % Margin | -4,996.7% | -2,361.6% | -1,203% | -4,266.7% |
| EPS Diluted | -1.59 | -1.5 | -1.3 | -1.91 |
| % Growth | -6% | -15.4% | 31.9% | – |
| Operating Cash Flow | -$66,618 | -$68,897 | -$85,175 | -$69,531 |
| Capital Expenditures | -$63 | -$407 | -$236 | -$117 |
| Free Cash Flow | -$66,681 | -$69,304 | -$85,411 | -$69,648 |